Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Enesi Pharma Limited
Enesi Pharma Limited
Activities:
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Memel Biotech and Therabest collaborate to develop exosome-based cell therapies
The partnership will aim to develop, manufacture and distribute novel exosome cell therapies in a range of therapeutic areas
Ipsen and Skyhawk Therapeutics partner to develop RNA-targeting drug candidates
The USD $1.8bn deal will support the development of novel RNA-modulating drugs using Skyhawk's proprietary technology
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Research & Development
Enesi Pharma and NIAID to test novel flu vaccines
The vaccines will be developed using Enesi Pharma’s ImplaVax technology
Ingredients
Enesi Pharma hits milestone in thermostable solid-dose live vaccines development
Enesi has achieved a key milestone in development of thermostable solid-dose live vaccines against measles and rubella
Drug Delivery
Enesi and Oxford Vaccine Group partner to immunise against plague
Collaboration aims to create an easy-to-use solid dose plague vaccine for use in areas of outbreak and as a defence against bioterrorism
Media
Needle-free vaccine collaboration for emergent threat pathogens
Enesi Pharma has entered a research and development collaboration with Public Health England
Pharmaceutical
Enesi welcomes global vaccine expert to Scientific Advisory Board
Subscribe now